To date, more than 60 VA medical centers have been involved in trials on COVID-19 therapeutics (see sidebar), including antiviral drugs such as remdesivir, monoclonal antibodies, convalescent plasma, and immunomodulators. Other therapeutics are in the pipeline for clinical trials, but only one has received FDA approval.

The post Navigating the COVID-19 pandemic: VA plays key role in identifying drugs to treat patients with the virus appeared first on VAntage Point.

Doctors Caucus confers on how VA’s academic affiliations and training programs enhance Veteran care and health professions education.

The post VA’s health professions education the focus of rounddiv appeared first on VAntage Point.

While there has been a significant and encouraging response to the dire need for blood across the nation, the American Red Cross needs more people to give in the weeks ahead to recover from its worst blood shortage in more than a decade.

The post Blood and platelet donation appointments still critically needed amid first-ever Red Cross blood crisis appeared first on VAntage Point.